Profile
AEMD ABT BSX-PA BSX SYK MDT
Company Name Aethlon Medical, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $3.62M $219.55B $175.45B $155.22B $149.38B $115.62B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO James B. Frakes Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
AEMD ABT BSX-PA BSX SYK MDT
Quant Rating Score 3 1 1 3 3
Quant Rating Neutral Strong Sell Strong Sell Neutral Neutral
Trading
AEMD ABT BSX-PA BSX SYK MDT
Last Close $1.19 $126.19 $122.18 $104.92 $392.73 $90.24
High 52 $2.3 $140.22 $122.18 $107.76 $403.53 $94.5
Low 52 $0.26 $107.8 $122.18 $72.96 $315.94 $79.61
Price vs. 52 Week High -48.26 % -10.01 % 0 % -2.64 % -2.68 % -4.51 %
Price vs. 52 Week Low 357.69 % 17.06 % 0 % 43.8 % 24.31 % 13.35 %
Total Return
AEMD ABT BSX-PA BSX SYK MDT
1 Month Return 0.85 % -7.39 % 0 % 0.13 % -1.01 % 1.68 %
3 Month Return 213.9 % -3.58 % 0 % 1.68 % 5.01 % 7.99 %
6 Month Return 70.02 % -1.36 % 0 % 2.5 % 0.37 % -0.64 %
9 Month Return 209.41 % 6.4 % 0 % 25.47 % 6.97 % 0.19 %
YTD Return 38.37 % 11.56 % 0 % 17.47 % 9.08 % 12.97 %
1 Year Return 258.43 % 14.56 % 0 % 39.6 % 17.88 % 12.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AEMD ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.84 % - - 0.85 % 3.11 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.44 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 27.93 % 0.92 % 0.92 % 43.2 % 76.97 %
Growth
AEMD ABT BSX-PA BSX SYK MDT
Asset Growth -10.75 % 11.2 % 12.12 % 12.12 % 7.66 % 1.89 %
Gross Profit Growth 100 % 5.01 % 16.12 % 16.12 % 10.25 % 3.88 %
Revenue Growth - 4.59 % 17.61 % 17.61 % 10.23 % 3.62 %
Revenue 3 Year -100 % -0.18 % 36.16 % 36.16 % 30.69 % 10.52 %
Revenue 5 Year -100 % 34.24 % 47.52 % 47.52 % 49.02 % 20.96 %
Revenue 10 Year -100 % 80.43 % 104.22 % 104.22 % 132.01 % 41.05 %
EBIT Growth -9.58 % 3.71 % 14.98 % 14.98 % 19.46 % -100 %
Net Income Growth -9.67 % 134.18 % 16.38 % 16.38 % -5.43 % 26.82 %
Net Income 3 Yeari Growth Per Share -21.55 % 94.27 % 72.14 % 72.14 % 48.52 % -3.39 %
Net Income 5 Yeari Growth Per Share 54.05 % 271.11 % -62.7 % -62.7 % 41.05 % 1.52 %
Net Income 10 Yeari Growth Per Share 95.29 % 410.99 % 524.92 % 524.92 % 477.35 % 48.51 %
Operating Income Growth 26.08 % 5.36 % 11.1 % 11.1 % -5.12 % 15.77 %
Operating Cash Flow Growth (CFG) 24.52 % 17.86 % 37.24 % 37.24 % 14.31 % 3.79 %
Operating 3 Year CFG 25.98 % -16.72 % 77.55 % 77.55 % 28.64 % 0.13 %
Operating 5 Year CFG 67.82 % 42.4 % 76.92 % 76.92 % 90.05 % 1.55 %
Operating 10 Year CFG 96.38 % 102.79 % 143.61 % 143.61 % 136.49 % 22.45 %
EPS Growth -76.54 % 134.55 % 16.67 % 16.67 % -5.76 % 31.05 %
EPS Diluted Growth -76.54 % 133.64 % 16.82 % 16.82 % -5.94 % 30.8 %
Book Value Per Share 43.06 % 23.54 % 11.25 % 11.25 % 10.57 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -71.72 % 36.46 % 26.58 % 26.58 % 37.24 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -88.09 % 56.53 % 48.35 % 48.35 % 58.15 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -80.11 % 92.83 % 186.31 % 186.31 % 138.47 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 6.63 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 26.97 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 53.81 % 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 162.12 % 128.74 %
Debt Growth -30.9 % -5.37 % 17.44 % 17.44 % 4.63 % 9.48 %
Free Cash Flow Growth 26.35 % 25.54 % 55.31 % 55.31 % 11.19 % -0.29 %
Updated On 31 Mar 2025 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
AEMD ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM - 56.14 % 68.27 % 68.27 % 63.57 % 64.06 %
Return on Assets TTM -181.91 % 17.16 % 6.24 % 6.24 % 6.21 % 5.09 %
Return on Equity TTM -221.38 % 31.84 % 11.78 % 11.78 % 10.73 % 9.62 %
Return on Capital Employed TTM - 11.05 % 8.97 % 8.97 % 9.61 % 7.56 %
Net Income Per EBT TTM 100 % 176.99 % 83.5 % 83.5 % 85.78 % 82.85 %
EBT Per Ebit TTM - 104.44 % 95.3 % 95.3 % 91.04 % 94.51 %
EBIT Per Revenue TTM - 17.54 % 17.02 % 17.02 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -1176.69 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM - 4.46 6.87 6.87 5.86 5.15
Payables Turnover TTM - 4.49 5.85 5.85 - 4.74
Inventory Turnover TTM - 2.85 2.05 2.05 1.66 2.12
Fixed Asset Turnover TTM - 394.34 % 481.99 % 481.99 % 656.62 % 490.52 %
Asset Turnover TTM - 52.93 % 46.07 % 46.07 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -4.9 5.15 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -4.9 3.83 1.94 1.94 9.37 4.04
Cash Per Share TTM 352.42 % 393.83 % 49.04 % 49.04 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM - 20.76 % 20.61 % 20.61 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -1176.69 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -0.47 32.98 54.83 54.03 41.76 22.3
Price To Operating Cash Flows Ratio TTM -0.29 24.5 41.29 40.69 34.79 16.43
Price Cash Flow Ratio TTM -0.29 24.5 41.29 40.69 34.79 16.43
Income Statement (TTM)
AEMD ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 0% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.01B $10.83B $3.86B $3.86B $5.72B $5.96B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -8.58 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AEMD ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.19B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.01B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AEMD ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 127.285
ADGM Adagio Medical Holdings, Inc. 1.26
AFIB Acutus Medical, Inc. 0.0005
AHCO AdaptHealth Corp. 8.755
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 136.5
ALUR Allurion Technologies Inc. 2.76
AMIX Autonomix Medical, Inc. Common Stock 1.38
ANIK Anika Therapeutics, Inc. 8.68
AORT Artivion, Inc. 30.94
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.75
ARAY Accuray Incorporated 1.27
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.78
AVNS Avanos Medical, Inc. 10.99
AVR Anteris Technologies Global Corp. Common Stock 3.09
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 12.66
ETFs With Exposure to AEMD
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.85
VXF Vanguard Extended Market Index Fund 0 193.54
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.98
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.99
VEMPX Vanguard Extended Market Index InstlPlus 0 370.12
Unlock